Xspray Pharma AB Statistics

Total Valuation

Xspray Pharma AB has a market cap or net worth of SEK 1.75 billion. The enterprise value is 1.65 billion.

Market Cap	1.75B
Enterprise Value	1.65B

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

Xspray Pharma AB has 33.76 million shares outstanding.

Shares Outstanding	33.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.84%
Owned by Institutions (%)	39.02%
Float	22.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.61
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.70
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.26

Financial Position

The company has a current ratio of 4.67, with a Debt / Equity ratio of 5.21.

Current Ratio	4.67
Quick Ratio	3.43
Debt / Equity	5.21
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-1,607.81

Financial Efficiency

Return on equity (ROE) is -37.74% and return on invested capital (ROIC) is -22.94%.

Return on Equity (ROE)	-37.74%
Return on Assets (ROA)	-20.76%
Return on Capital (ROIC)	-22.94%
Revenue Per Employee	n/a
Profits Per Employee	-8.26M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.56% in the last 52 weeks. The beta is 0.92, so Xspray Pharma AB's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	+61.56%
50-Day Moving Average	65.23
200-Day Moving Average	50.10
Relative Strength Index (RSI)	42.34
Average Volume (20 Days)	29,475

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-215.45M
Pretax Income	-214.86M
Net Income	-214.76M
EBITDA	-208.42M
EBIT	-215.45M
Earnings Per Share (EPS)	-6.88

Balance Sheet

The company has 126.57 million in cash and 34.84 million in debt, giving a net cash position of 91.74 million or 2.72 per share.

Cash & Cash Equivalents	126.57M
Total Debt	34.84M
Net Cash	91.74M
Net Cash Per Share	2.72
Equity (Book Value)	668.14M
Book Value Per Share	19.79
Working Capital	139.72M

Cash Flow

In the last 12 months, operating cash flow was -220.73 million and capital expenditures -7.07 million, giving a free cash flow of -227.80 million.

Operating Cash Flow	-220.73M
Capital Expenditures	-7.07M
Free Cash Flow	-227.80M
FCF Per Share	-6.75

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Xspray Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-13.30%
FCF Yield	-13.05%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a